Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Chemical contamination & hidden ingredients

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines.

709 FDA drug recalls with this cause, newest first.

This category covers two things the label never mentions. One is chemical contamination: benzene in sunscreens and hand sanitizers, methanol in sanitizer, lead or other heavy metals in a finished product. The other is a 'supplement' that secretly contains a prescription drug - sildenafil, tadalafil, sibutramine, phenolphthalein - so that it appears to work, at the cost of dangerous interactions the buyer cannot anticipate. A large share of these recalls are Class I, because the hidden ingredient is the whole risk.

Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-363-90 D-1106-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-362-90 D-1105-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-361-90 D-1104-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-360-30 D-1103-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-363-90 D-0876-2018
Class I · High risk

7K capsules packaged in single packs sold in 24-count boxes

Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared Shoreside Enterprises Inc. D-0880-2018
Class I · High risk

POSEIDON Xtreme PLATINUM 4500

Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared Shoreside Enterprises Inc. D-0879-2018
Class II · Moderate risk

screamin' menthol

CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.

Terminated Chemical / undeclared Ideaz Llc D-0835-2018
Class II · Moderate risk

screamin' hot

CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.

Terminated Chemical / undeclared Ideaz Llc D-0834-2018
Class I · High risk

Rhino 69 Extreme 50000 packaged in 1 capsule per blister pack

Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

Terminated Chemical / undeclared AMA Wholesale D-0821-2018
Class I · High risk

Red Zone Xtreme 3000 Capsules

Marketed without an Approved NDA/ANDA; FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.

Terminated Chemical / undeclared Jimmy Weber D-0625-2018
Class I · High risk

Bella Capsules

Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.

Terminated Chemical / undeclared Bella All Natural D-0593-2018
Class III · Low risk

Bull Capsules

Marketed without an Approved NDA/ANDA; product found to be tainted with sildenafil

Terminated Chemical / undeclared BYL Solutions Inc. D-0414-2018
Class I · High risk

BLUE PEARL capsules

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Terminated Chemical / undeclared Blue Fusion Natural D-0247-2018
Class I · High risk

Hard Times For Men capsules

Marketed without an approved NDA/ANDA: Product contains undeclared active pharmaceutical ingredient (API) - Sildenafil.

Terminated Chemical / undeclared www.blankterrmall.com D-0470-2018
Class II · Moderate risk

A1 Slim

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Terminated Chemical / undeclared Kiriko, LLC. D-0058-2018
Class I · High risk

grande X 5800 capsule

Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

Terminated Chemical / undeclared Gadget Island, Inc D-0106-2018
Class I · High risk

FIFTY SHADES 6000 capsule

Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

Terminated Chemical / undeclared Gadget Island, Inc D-0105-2018
Class I · High risk

PapaZen 3300 capsule

Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.

Terminated Chemical / undeclared Gadget Island, Inc D-0104-2018